Curis | CRIS - Gross Profit On Sales


Curis reported $1.14M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Amgen USD 5.87B 1.02B Mar/2026
AstraZeneca USD 12.86B 251M Jun/2026
Bayer EUR 6.33B 1.84B Jun/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
CSL USD 4.46B 2.71B Dec/2025
Curis USD 1.14M 8.86M Dec/2025
Eli Lilly USD 16.22B 301.7M Mar/2026
Exelixis USD 608.03M 17.17M Jun/2026
Gilead Sciences USD 6.8B 1.29B Jun/2026
GlaxoSmithKline GBP 6.51B 757M Jun/2026
Incyte USD 1.57B 400.89M Jun/2026
Merck USD 12.09B 1.24B Mar/2026
Novartis USD 11.24B 1.18B Jun/2026
Pfizer USD -248M 11.29B Jun/2026
Roche Holding CHF 22.69B 600M Jun/2026
Sanofi EUR 8.71B 602M Jun/2026
Takeda JPY 813.22B 124.39B Jun/2026
TG Therapeutics USD 199.14M 27.73M Jun/2026
Verastem USD 15.62M 977K Mar/2026